Printer Friendly

Pulse Biosciences announces non-qualified stock options to four new non-executive employees.

M2 EQUITYBITES-September 20, 2018-Pulse Biosciences announces non-qualified stock options to four new non-executive employees

(C)2018 M2 COMMUNICATIONS http://www.m2.com

Medical technology company Pulse Biosciences Inc (NASDAQ:PLSE) said on Wednesday that the board of directors' compensation committee has granted non-qualified stock options to four new non-executive employees in accordance with Nasdaq Marketplace Rule 5635(c)(4).

The company has awarded granted non-qualified stock options covering an aggregate of 34,250 shares of its common stock to four new non-executive employees.

In addition,the company's options have an exercise price of USD14.59 per share, which is equal to the closing price of its common stock on 17 September 2018.

Subject to the recipient's continued employment with the company on these vesting dates, the 34,250 shares underlying the option grants will vest and become exercisable as to 25% of the shares on the first anniversary of the recipient's start date and will vest and become exercisable as to the remaining 75% of the shares in 36 equal monthly instalments following the first anniversary of the recipient's start date.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2018 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Sep 20, 2018
Words:192
Previous Article:Agilent Technologies sets dividend payment date of 24 October 2018.
Next Article:EnviroStar Inc to close acquisition of laundry service business.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters